Your browser doesn't support javascript.
loading
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.
Reyes, Monica E; Fujii, Takeo; Branstetter, Daniel; Krishnamurthy, Savitri; Masuda, Hiroko; Wang, Xiaoping; Reuben, James M; Woodward, Wendy A; Edwards, Beatrice J; Hortobagyi, Gabriel N; Tripathy, Debu; Dougall, William C; Eckhardt, Bedrich L; Ueno, Naoto T.
Afiliação
  • Reyes ME; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fujii T; Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Branstetter D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Krishnamurthy S; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Masuda H; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Wang X; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.
  • Reuben JM; Department of Pathology, Amgen, Inc., Seattle, WA, USA.
  • Woodward WA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Edwards BJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hortobagyi GN; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tripathy D; Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dougall WC; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Eckhardt BL; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ueno NT; Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Breast Cancer Res Treat ; 164(1): 57-67, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28417335
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Ligante RANK / Receptor Ativador de Fator Nuclear kappa-B / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Ligante RANK / Receptor Ativador de Fator Nuclear kappa-B / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article